JLJoanne Lau

Joanne Lau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Joanne Lau has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Jialing Lee

    Expression Engineering Group, Bioprocessing Technology Institute, 20 Biopolis Way, #06-01 Centros, Singapore 138668, Singapore,1 Department of Biochemistry and Molecular Biology, George Washington University School of Medicine, Washington, DC 200372

    3 shared publications
  • Sheng-Hao Chao

    School of Materials Science and Engineering

    3 shared publications
  • Anwesha Dey

    2 shared publications
  • David Philip Lane

    Department of Microbiology, Tumor and Cell Biology Karolinska Institute Solna Sweden

    2 shared publications
  • Meera Gurumurthy

    Expression Engineering Group, Bioprocessing Technology Institute, 20 Biopolis Way, #06-01 Centros, Singapore 138668, Singapore,1 Department of Biochemistry and Molecular Biology, George Washington University School of Medicine, Washington, DC 200372

    2 shared publications
  • Raymond Ng

    Expression Engineering Group, Bioprocessing Technology Institute, 20 Biopolis Way, #06-01 Centros, Singapore 138668, Singapore,1 Department of Biochemistry and Molecular Biology, George Washington University School of Medicine, Washington, DC 200372

    2 shared publications

Latest Publications

  • A Phosphosignaling Adaptor Primes the AAA+ Protease ClpXP to Drive Cell Cycle-Regulated Proteolysis

    by Joanne Lau, Lisa Hernandez-Alicea, Robert H. Vass, Peter Chien


  • Open Access

    Genome and Transcriptome of Clostridium phytofermentans, Catalyst for the Direct Conversion of Plant Feedstocks to Fuels

    by Elsa Petit, Maddalena V Coppi, James C Hayes, Andrew C Tolonen, Thomas Warnick, William G Latouf, Danielle Amisano, Amy Biddle, Supratim Mukherjee, Natalia Ivanova, et al.

    Clostridium phytofermentans was isolated from forest soil and is distinguished by its capacity to directly ferment plant cell wall polysaccharides into ethanol as the primary product, suggesting that it possesses unusual catabolic pathways. The objective of the present study was to understand the molecular mechanisms of biomass conversion to ethanol in a single organism, Clostridium phytofermentans, by analyzing its complete genome and transcriptome during growth on plant carbohydrates. The saccharolytic versatility of C. phytofermentans is reflected in a diversity of genes encoding ATP-binding cassette sugar transporters and glycoside hydrolases, many of which may have been acquired through horizontal gene transfer. These genes are frequently organized as operons that may be controlled individually by the many transcriptional regulators identified in the genome. Preferential ethanol production may be due to high levels of expression of multiple ethanol dehydrogenases and additional pathways maximizing ethanol yield. The genome also encodes three different proteinaceous bacterial microcompartments with the capacity to compartmentalize pathways that divert fermentation intermediates to various products. These characteristics make C. phytofermentans an attractive resource for improving the efficiency and speed of biomass conversion to biofuels.


  • Electrical Conductivity in a Mixed-Species Biofilm

    by Nikhil S. Malvankar, Joanne Lau, Kelly P. Nevin, Ashley E. Franks, Mark T. Tuominen, Derek R. Lovley

    Geobacter sulfurreducens can form electrically conductive biofilms, but the potential for conductivity through mixed-species biofilms has not been examined. A current-producing biofilm grown from a wastewater sludge inoculum was highly conductive with low charge transfer resistance even though microorganisms other than Geobacteraceae accounted for nearly half the microbial community.


  • Ubiquitination of HEXIM1 by HDM2

    by Joanne Lau, Qiao Jing Lew, Gaelle Diribarne, Annemieke A. Michels, Anwesha Dey, Olivier Bensaude, David P. Lane, Sheng-Hao Chao

    Hexamethylene bis-acetamide inducible protein 1 (HEXIM1) is an inhibitor of the positive transcription elongation factor b (P-TEFb), which controls RNA polymerase II transcription and human immunodeficiency virus Tat transactivation. In cells, more than half of P-TEFb is associated with HEXIM1 resulting in the inactivation of P-TEFb. Recently, we found that nucleophosmin (NPM), a key factor involved in p53 signaling pathway, interacts with HEXIM1 and activates P-TEFb-dependent transcription. Here we report that human double minute-2 protein (HDM2), a p53-specific E3 ubiquitin ligase, specifically ubiquitinates HEXIM1 through the lysine residues located within the basic region of HEXIM1. However, the HDM2-induced HEXIM1 ubiquitination does not lead to proteasome-mediated protein degradation. Fusion of ubiquitin to HEXIM1 demonstrates stronger inhibition on P-TEFb-dependent transcription. Our results demonstrate that HDM2 functions as a specific E3 ubiquitin ligase for HEXIM1, suggesting a possible r...


  • XBP-1, a Novel Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Binding Protein, Activates HTLV-1 Basal and Tax-Activated Transcription

    by Sebastian C. Y. Ku, Jialing Lee, Joanne Lau, Meera Gurumurthy, Raymond Ng, Siew Hui Lwa, Joseph Lee, Zachary Klase, Fatah Kashanchi, Sheng-Hao Chao

    X-box binding protein 1 (XBP-1), a basic leucine zipper transcription factor, plays a key role in the cellular unfolded protein response (UPR). There are two XBP-1 isoforms in cells, spliced XBP-1S and unspliced XBP-1U. XBP-1U has been shown to bind to the 21-bp Tax-responsive element of the human T-lymphotropic virus type 1 (HTLV-1) long terminal repeat (LTR) in vitro and transactivate HTLV-1 transcription. Here we identify XBP-1S as a transcription activator of HTLV-1. Compared to XBP-1U, XBP-1S demonstrates stronger activating effects on both basal and Tax-activated HTLV-1 transcription in cells. Our results show that both XBP-1S and XBP-1U interact with Tax and bind to the HTLV-1 LTR in vivo. In addition, elevated mRNA levels of the gene for XBP-1 and several UPR genes were detected in the HTLV-1-infected C10/MJ and MT2 T-cell lines, suggesting that HTLV-1 infection may trigger the UPR in host cells. We also identify Tax as a positive regulator of the expression of the gene for XBP-1. Activation of the UPR by tunicamycin showed no effect on the HTLV-1 LTR, suggesting that HTLV-1 transcription is specifically regulated by XBP-1. Collectively, our study demonstrates a novel host-virus interaction between a cellular factor XBP-1 and transcriptional regulation of HTLV-1.


  • Nucleophosmin Interacts with HEXIM1 and Regulates RNA Polymerase II Transcription

    by Meera Gurumurthy, Chuan Hao Tan, Raymond Ng, Lisa Zeiger, Joanne Lau, Jialing Lee, Anwesha Dey, Robin Philp, Qintong Li, Tit Meng Lim, et al.


  • Cell-specific effects of human cytomegalovirus unique region on recombinant protein expression

    by Jialing Lee, Joanne Lau, Grace Chong, Sheng-Hao Chao

    The major immediate-early (MIE) promoter of human cytomegalovirus (CMV) is widely used to express recombinant proteins in mammalian cells. CMV MIE promoter contains a strong enhancer and an AT-rich unique region (UR). The UR can function as an insulator or a negative element of CMV MIE promoter, depending on the cellular proteins associated with it. To examine the effects of UR on recombinant protein expression in mammalian cells, we constructed two CMV MIE promoter-based expression plasmids for comparison to the conventional CMV MIE promoter by removing or adding UR. Addition of UR enhances transgene expression in HEK293 stable cells while removal of UR increases both transient and stably integrated expression in HeLa cells. Our results further demonstrate that the cell-specific effect of UR depends on the protein levels of UR-binding proteins, pancreatic-duodenal homeobox factor-1, special AT-rich sequence binding protein 1, and CCAAT displacement protein, in these cells. Collectively, these modified CMV expression plasmids can be utilized to improve recombinant protein production in specific mammalian cell lines.